Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care? | Zendy

Jason Akerman | Zendy; Jason R. Kovac | Zendy

Open Access

Treatment of Peyronie’s disease via preoperative intralesional collagenase clostridium histolyticum followed by placement of an inflatable penile prosthesis: the new standard of care?

Author(s) -

Jason Akerman,

Jason R. Kovac

Publication year - 2017

Publication title -

translational andrology and urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.721

H-Index - 27

eISSN - 2223-4691

pISSN - 2223-4683

DOI - 10.21037/tau.2017.11.04

Subject(s) - peyronie's disease , penile prosthesis , medicine , prosthesis , erectile dysfunction , penis , surgery

Penile prosthetic surgery via insertion of an inflatable penile prosthesis (IPP) is well established as the gold standard for patients with Peyronie’s disease and concurrent, severe erectile dysfunction (ED). For these patients, correction of curvature, erectile strength, and penile shortening have a significant impact on overall satisfaction and quality of life (1,2).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research